Literature DB >> 16159978

Diabetic heart disease.

T H Marwick1.   

Abstract

Diabetes mellitus is responsible for a spectrum of cardiovascular disease. The best known complications arise from endothelial dysfunction, oxidation, inflammation, and vascular remodelling and contribute to atherogenesis. However, the effects on the heart also relate to concurrent hypertensive heart disease, as well as direct effects of diabetes on the myocardium. Diabetic heart disease, defined as myocardial disease in patients with diabetes that cannot be ascribed to hypertension, coronary artery disease, or other known cardiac disease, is reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 16159978      PMCID: PMC1860832          DOI: 10.1136/hrt.2005.067231

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  37 in total

1.  Evaluation of the longitudinal contraction of the left ventricle in normal subjects by Doppler tissue tracking and strain rate.

Authors:  Niels Holmark Andersen; Steen Hvitfeldt Poulsen
Journal:  J Am Soc Echocardiogr       Date:  2003-07       Impact factor: 5.251

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.

Authors:  Riccardo Candido; Josephine M Forbes; Merlin C Thomas; Vicki Thallas; Rachael G Dean; Wendy C Burns; Christos Tikellis; Rebecca H Ritchie; Stephen M Twigg; Mark E Cooper; Louise M Burrell
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

4.  Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin.

Authors:  Dragos Vinereanu; Eleftherios Nicolaides; Ann C Tweddel; Christoph F Mädler; Ben Holst; Lucy E Boden; Mircea Cinteza; Alan E Rees; Alan G Fraser
Journal:  Clin Sci (Lond)       Date:  2003-11       Impact factor: 6.124

5.  Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance.

Authors:  Gerald F Watts; Thomas H Marwick
Journal:  Clin Sci (Lond)       Date:  2003-11       Impact factor: 6.124

Review 6.  Heart failure: the frequent, forgotten, and often fatal complication of diabetes.

Authors:  David S H Bell
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

7.  Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.

Authors:  Jing Liu; Malthi R Masurekar; Dorothy E Vatner; Garikiparthy N Jyothirmayi; Timothy J Regan; Stephen F Vatner; Leonard G Meggs; Ashwani Malhotra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-28       Impact factor: 4.733

8.  Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Authors:  Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

9.  Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.

Authors:  Jennifer E Liu; David C Robbins; Vittorio Palmieri; Jonathan N Bella; Mary J Roman; Richard Fabsitz; Barbara V Howard; Thomas K Welty; Elisa T Lee; Richard B Devereux
Journal:  J Am Coll Cardiol       Date:  2003-06-04       Impact factor: 24.094

10.  Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine.

Authors:  Zhi You Fang; Ofelia Najos-Valencia; Rodel Leano; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

View more
  27 in total

Review 1.  [Diabetes mellitus, coronary artery disease and heart disease].

Authors:  Martin Clodi; Christoph Säly; Friedrich Hoppichler; Michael Resl; Clemens Steinwender; Bernd Eber
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

2.  Subclinical impairment of left ventricular function in diabetic patients with or without obesity: A study based on three-dimensional speckle tracking echocardiography.

Authors:  Q Wang; Y Gao; K Tan; P Li
Journal:  Herz       Date:  2014-12-11       Impact factor: 1.443

3.  Diabetes status modifies the association between carotid intima-media thickness and incident heart failure: The Atherosclerosis Risk in Communities study.

Authors:  Valery S Effoe; Eric E McClendon; Carlos J Rodriguez; Lynne E Wagenknecht; Gregory W Evans; Patricia P Chang; Alain G Bertoni
Journal:  Diabetes Res Clin Pract       Date:  2017-04-13       Impact factor: 5.602

4.  Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.

Authors:  A M Papinska; N M Mordwinkin; C J Meeks; S S Jadhav; K E Rodgers
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

5.  Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.

Authors:  Anna Biernacka; Michele Cavalera; Junhong Wang; Ilaria Russo; Arti Shinde; Ping Kong; Carlos Gonzalez-Quesada; Vikrant Rai; Marcin Dobaczewski; Dong-Wook Lee; Xiao-Fan Wang; Nikolaos G Frangogiannis
Journal:  Circ Heart Fail       Date:  2015-05-18       Impact factor: 8.790

6.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

Review 7.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

8.  Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population.

Authors:  Joji Ishikawa; Shizukiyo Ishikawa; Tomoyuki Kabutoya; Tadao Gotoh; Kazunori Kayaba; Joseph E Schwartz; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  Hypertension       Date:  2008-11-17       Impact factor: 10.190

9.  Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

Authors:  Carlos Gonzalez-Quesada; Michele Cavalera; Anna Biernacka; Ping Kong; Dong-Wook Lee; Amit Saxena; Olga Frunza; Marcin Dobaczewski; Arti Shinde; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2013-09-30       Impact factor: 17.367

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.